Drugs /
volasertib
Back to Drugs List
Associated Genetic Biomarkers
Overview
Clinical Trials
Volasertib has been investigated in 2 clinical trials, of which 0 are open and 2 are closed. Of the trials investigating volasertib, 2 are phase 1 (0 open).
CBFB-MYH11 Fusion, RUNX1-RUNX1T1 Fusion, and inv(16)(p13q22) are the most frequent biomarker inclusion criteria for volasertib clinical trials.
Acute myeloid leukemia is the most common disease being investigated in volasertib clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.